This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coagulation Defects
and you are
between 18 and 55
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study is a Phase 1, single-center, open-label, ascending dose study which will assess the safety and tolerability of 5 doses of spray-dried solvent/detergent treated plasma (Resusix®) in healthy volunteers.

Provided treatments

  • Biological: Spray-dried S/D-treated Plasma
  • Drug: Spray-dried S/D-treated plasma
  • Biological: Spray-dried S/D-treated Plasma
  • Biological: Spray-dried S/D-treated Plasma
  • Biological: Spray-dried S/D-treated Plasma

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01589666. The sponsor of the trial is Entegrion, Inc. and it is looking for 27 volunteers for the current phase.
Official trial title:
Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers